364 related articles for article (PubMed ID: 29373210)
1. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
[TBL] [Abstract][Full Text] [Related]
3. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
Zhang Y; Xiong X; Fu Z; Dai H; Yao F; Liu D; Deng S; Hu C
Eur J Radiol; 2019 Nov; 120():108695. PubMed ID: 31589995
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
[TBL] [Abstract][Full Text] [Related]
5. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
[No Abstract] [Full Text] [Related]
7. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
Park HY; Kim KW; Yoon MA; Lee MH; Chae EJ; Lee JH; Chung HW; Yoon DH
Cancer Imaging; 2020 Jan; 20(1):14. PubMed ID: 32000858
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
[TBL] [Abstract][Full Text] [Related]
9. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
[TBL] [Abstract][Full Text] [Related]
10. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
Latifoltojar A; Hall-Craggs M; Bainbridge A; Rabin N; Popat R; Rismani A; D'Sa S; Dikaios N; Sokolska M; Antonelli M; Ourselin S; Yong K; Taylor SA; Halligan S; Punwani S
Eur Radiol; 2017 Dec; 27(12):5325-5336. PubMed ID: 28656463
[TBL] [Abstract][Full Text] [Related]
11. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
[TBL] [Abstract][Full Text] [Related]
12. Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma.
Wang J; Zhang B; Zhang R; Zhang L; Jiang W; Jiang Y
Medicine (Baltimore); 2021 Sep; 100(35):e27131. PubMed ID: 34477159
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.
Perl RM; Gronbach F; Fritz J; Horger MS; Hepp T
Eur J Radiol; 2020 Nov; 132():109306. PubMed ID: 33038578
[TBL] [Abstract][Full Text] [Related]
15. [Role of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma].
Wang PF; Li YC; Xu Y; Wang XM; Guo L; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):129-133. PubMed ID: 28279037
[No Abstract] [Full Text] [Related]
16. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
[TBL] [Abstract][Full Text] [Related]
17. Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma.
Zhang B; Bian B; Zhao Z; Lin F; Zhu Z; Lou M
BMC Med Imaging; 2021 Jun; 21(1):98. PubMed ID: 34103001
[TBL] [Abstract][Full Text] [Related]
18. Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis.
Wang K; Lee E; Kenis S; Hallam S; Haroon A; Wan S; Rabin N; Rojas-Garcia A; Padhani A; Adeleke S
Eur Radiol; 2022 Apr; 32(4):2135-2148. PubMed ID: 35028748
[TBL] [Abstract][Full Text] [Related]
19. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
Latifoltojar A; Hall-Craggs M; Rabin N; Popat R; Bainbridge A; Dikaios N; Sokolska M; Rismani A; D'Sa S; Punwani S; Yong K
Br J Haematol; 2017 Jan; 176(2):222-233. PubMed ID: 27766627
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of WB-DWI versus
Zhang B; Zhang L; Bian B; Lin F; Zhu Z; Wang J
Indian J Cancer; 2023; 60(3):303-309. PubMed ID: 37787189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]